Rose Capital is a leading investment firm within the global legal cannabis sector that is focused on providing strategic capital and fostering growth-oriented operating partnerships.
Rose Capital partners with talented operating and management teams. We create bespoke investment structures to service cannabis operators’ goals. Our focus is on three verticals: data & analysis, distribution & logistics, consumer packaged goods & ancillary products.
Our origins in cannabis date back to 2009, when our founders initiated diligence on the industry. In 2014, after analyzing dozens of assets, Rose made its inaugural investment. Over the last five years, our portfolio has grown to encompass some of the cannabis industry’s most prominent and powerful names.
We are a diverse team of professionals that leverages our experience in the cannabis markets, financial acumen, expertise of capital markets and strategic advisory abilities to unlock opportunities for operating teams, employees, and investors. With aims of maximizing upside yield while mitigating downside risk, our assets work synergistically to deliver outsized returns.
Rose Capital is the founder and exclusive financial partner of BR Brands, a leading cannabis CPG platform that unites best-in-class brands though a buy and build strategy. BR Brands possesses one of the most diverse product portfolios in the industry and an unmatched geographic footprint.
Rose Capital is a long-term value-oriented investment platform, rooted in partnership with talented operating teams. In partnership with management, we create bespoke investment structures that service cannabis operators’ goals with a focus on the verticals of data & analytics, distribution & logistics, consumer packaged goods and ancillary products.
With a team that possesses exceptional financial service pedigrees, ranging from distressed credit to both private and public equity expertise.
We are opportunistic in designing tailored investment structures to meet the individual needs of our operators and assets.
Our background in executing complicated transactions provides a competitive advantage in addressing the unique needs of each operating partner. These needs, coupled with macroeconomic considerations, inform Rose’s investment structures, which span across the spectrum of traditional lending, growth equity, control buyouts, distressed lending / restructurings, as well as public investing.
BR Brands and Dixie Brands to Complete Merger to Form BellRock Brands on October 31st; Stock Symbol to be Changed to “BRCK”
Rebel Coast, a California-based Creator of Cannabis-infused Beverages, Expands Product Line to Include Sparkling Wine and Seltzers
BR Brands and Dixie Agree to Combine, Creating Market-Leading CPG Platform
Today, BR Brands LLC (“BR Brands”), a premier house of brands within the legal cannabis sector, and Dixie Brands Inc. (“Dixie”) (CSE: DIXI.U), (OTCQX: DXBRF), (Frankfurt: 0QV), one of the cannabis industry’s most recognized consumer packaged goods companies, have signed an exclusive, binding term sheet to merge.
BR Brands™ Appoints Jacques Panis as Mary’s Brands™ Chief Executive Officer
BR Brands, LLC (“BR Brands”), a consumer packaged goods company within the global legal cannabis industry, announced today that Jacques Panis has been appointed Chief Executive Officer of Mary’s Brands™ (“Mary’s”).
Helix Technologies subsidiary BioTrack finishes key audit
The cannabis software firm BioTrack, a subsidiary of Helix Technologies Inc (OTCMKTS:HLIX) has made another advance, with news that it has completed its SOC2 Type II audit.
Helix Technologies’ Biotrack Traceability System Processes Over $11 Million in Transactions in First Week of IL Recreational Cannabis Sales
Helix Technologies, Inc. (OTCQB: HLIX) (the “Company”), the leading provider of critical infrastructure services to the legal cannabis industry, successfully completed the launch of the state tracking system for adult use marijuana sales in Illinois. The successful transition of the tracking system from medical to adult use allowed businesses to sell over $3.2 million of cannabis products on the first day of sales.
177 West Putnam Ave
Greenwich, CT, US 06831